Abstract
Detection of mobile thrombus of the thoracic aorta has become increasingly higher after any embolic event. Although the indication for treatment remains controversial, there is a growing interest about the ethiopathogenesis of this rare entity, and to define proper diagnostic and therapeutic approaches. The purpose of this article was to review the current management strategies and follow-up results of this rare pathology.
MeSH terms
-
Adult
-
Aged
-
Anticoagulants / therapeutic use
-
Aorta, Thoracic*
-
Aortic Diseases / complications
-
Aortic Diseases / diagnosis
-
Aortic Diseases / etiology
-
Aortic Diseases / therapy*
-
Embolism / etiology
-
Embolism / prevention & control*
-
Fibrinolytic Agents / therapeutic use
-
Humans
-
Middle Aged
-
Recurrence
-
Risk Factors
-
Thrombosis / complications
-
Thrombosis / diagnosis
-
Thrombosis / etiology
-
Thrombosis / therapy*
-
Treatment Outcome
-
Vascular Surgical Procedures
Substances
-
Anticoagulants
-
Fibrinolytic Agents